Is Cresanto Global Ltd (531207) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Cresanto Global Ltd is a below average quality company .

Is Cresanto Global Ltd (531207) undervalued or overvalued?

The key valuation ratios of Cresanto Global Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone .

What is Cresanto Global Ltd (531207) share price return in the past 10 years?

Cresanto Global Ltd share price has appreciated 3.5% annually (CAGR) over the past ten years.

Is Cresanto Global Ltd (531207) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Cresanto Global Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Cresanto Global Ltd (531207)?

Company share prices are keep on changing according to the market conditions. The current trading price of Cresanto Global Ltd (531207) on 02-Mar-2026 16:59:59 at 16:59 is 4.43.

What is the P/E ratio of Cresanto Global?

The latest standalone P/E ratio of Cresanto Global as of 02-Mar-2026 is 0.00.

What is the P/B ratio of Cresanto Global Ltd (531207)?

The latest standalone P/B ratio of Cresanto Global Ltd (531207) as of 02-Mar-2026 is -0.68.

What is the 52-week high and low of Cresanto Global Ltd (531207)?

The 52-week high of Cresanto Global Ltd (531207) is Rs. 4.43 and the 52-week low is Rs. 3.32.

Cresanto Global Ltd (531207) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Cresanto Global Ltd (531207)
Brand: Cresanto Global

Cresanto Global Ltd (531207) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Cresanto Global Ltd (531207)

BSE: 531207 NSE:

Key Metrics

Market Cap

₹2 Cr.

P/E Ratio

0.00

Price to Book (P/B)

-0.68

Price to Sales (P/S)

35.06

EV/EBITDA

-622.31

Return on Capital Employed (ROCE)

0.00%

Current Price

₹4.4

Return on Equity (ROE)

0.00%

Return on Assets (ROA)

-198.35%

Operating Profit Margin

Net Profit Margin

-INF%

Gross Profit Margin

Book Value per Share

₹-6.5

Sales Growth (YoY)

NA%

Sales Growth (3 Years)

NA%

Operating Profit Growth (1 Year)

NA%

Operating Profit Growth (3 Years)

N/A%

Net Profit Growth (1 Year)

NA%

52-Week Low / High

₹3 / 4

Net Profit Growth (3 Years)

N/A%

Dividend Yield

0.00%

Promoter Holding

32.27%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Cresanto Global Ltd?

Cresanto Global Ltd revenue growth is 0% for FY-2025 , which is in line with its 5 year CAGR of 0% , indicating stable growth.

Q.1 Promoter shareholding and pledge status of Cresanto Global Ltd?

Promoters hold 32.27% of the Cresanto Global Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Cresanto Global Ltd vs industry peers?

Cresanto Global Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 5.54% , indicating slower growth and losing its market share.

Q.1 Which industry/sub-sector does Cresanto Global Ltd belong to?

Cresanto Global Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.1 Stock return of Cresanto Global Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 3.5% based on the current price.

DeciZen - make an informed investing decision on Cresanto Global

Based on:

Data

M-Cap below 100cr DeciZen not available

Cresanto Global stock performance

Key Ratios

Is Cresanto Global Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	-15.6%	-26.4%	-41.3%	-58.4%	-105.5%	-94.4%	0%	0%	0%	0%	-
Value Creation Index ⓘ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	0	0	0	0	0	0	0	0
Sales YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	-
Adj EPS ⓘ	-0.1	-0.1	-0.1	-0.1	-0.1	-0.2	-0.2	-0.4	-0.2	-1.3	-0.3
YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	-4.1	-4.3	-4.4	-4.5	-4.6	-4.8	-5	-5.4	-5.6	-6.1	-6.5
Adj Net Profit ⓘ	-0	-0	-0	-0	-0.1	-0.1	-0.1	-0.2	-0.1	-0.5	-0
Cash Flow from Ops. ⓘ	0	0	0	0	-0	0	-2.2	-0.2	-0.1	-0.5	-
Debt/CF from Ops. ⓘ	370.5	24433.3	7705.3	1737.8	-7238.4	7046.6	0	0	-40.1	-5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	NA	NA
Adj EPS ⓘ	NA	NA	NA	NA
BVPSⓘ	NA	NA	NA	NA
Share Price	3.5%	36.1%	29.5%	39.8%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	1.3	1.9	2	1.7	2.9	3.4	3.9	7.7	4.3	21.5	4.6
Op. Profit Mgn % ⓘ	0	0	0	0	0	0	0	0	0	0	-14.8
Net Profit Mgn % ⓘ	0	0	0	0	0	0	0	0	0	0	-247.7
Debt to Equity ⓘ	-1.1	-1.1	-1.1	-1	-1	-1.1	0	0	-1	-0.9	-
Working Cap Days ⓘ	0	0	0	0	0	0	0	0	0	0	43
Cash Conv. Cycle ⓘ	0	0	0	0	0	0	0	0	0	0	-91

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	-0.3	-
TTM Sales (₹ Cr.)	0.1	-
BVPS (₹) ⓘ	-6.5	-
Reserves (₹ Cr.) ⓘ	-7	-
P/BV ⓘ	-0.68	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	3.32 / 4.43
All Time Low / High (₹)	0.92 / 46.90
Market Cap (₹ Cr.)	1.9
Equity (₹ Cr.)	4.3
Face Value (₹)	10
Industry PE ⓘ	42.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Cresanto Global - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	0	0	0	0	0	0	0	0	0	0
Operating Expenses ⓘ +	0.03	0.03	0.03	0.03	0.06	0.07	0.08	0.19	0.10	0.59
Manufacturing Costs	0	0	0	0	0	0	0	0	0	0
Material Costs	0	0	0	0	0	0	0	0	0	0
Employee Cost	0.01	0.01	0.01	0.01	0.02	0.02	0.03	0.04	0.04	0.15
Other Costs ⓘ	0.02	0.02	0.02	0.02	0.05	0.05	0.05	0.15	0.06	0.43
Operating Profit ⓘ	-0.03	-0.03	-0.03	-0.03	-0.06	-0.07	-0.08	-0.19	-0.10	-0.59
Operating Profit Margin (%)	-	-	-	-	-	-	-	-	-	-
Other Income ⓘ +	0.02	0.01	0.01	0.01	0.01	0.01	0	0.02	0	0.53
Exceptional Items ⓘ	-0.02	-0.02	-0.03	-0.03	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0	0	0	0.11
Depreciation ⓘ	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0	0
Profit Before Tax ⓘ	-0.04	-0.05	-0.06	-0.05	-0.06	-0.07	-0.08	-0.17	-0.10	-0.18
Tax ⓘ	0	0	0	0	0	0	0	0	0	0
Profit After Tax	-0.04	-0.05	-0.06	-0.05	-0.06	-0.07	-0.08	-0.17	-0.10	-0.18
PAT Margin (%)	-	-	-	-	-	-	-	-	-	-
Adjusted EPS (₹)	-0.1	-0.1	-0.1	-0.1	-0.1	-0.2	-0.2	-0.4	-0.2	-0.4
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	-1.77	-1.82	-1.87	-1.93	-1.98	-2.05	-2.13	-2.31	-2.41	-2.59
Share Capital ⓘ	4.27	4.27	4.27	4.27	4.27	4.27	4.27	4.27	4.27	4.27
Reserves ⓘ	-6.04	-6.09	-6.15	-6.20	-6.26	-6.33	-6.41	-6.58	-6.68	-6.86
Debt +	1.99	1.98	1.99	2	2.02	2.16	0	0	2.43	2.37
Long Term Debt	0	0	0	0	0	0	0	0	2.43	2.37
Short Term Debt	1.99	1.98	1.99	2	2.02	2.16	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0	0	0	0	0	0	0	0	0	0
Others Liabilities ⓘ	0.06	0.12	0.16	0.19	0.22	0.14	2.38	2.46	0.13	0.25
Total Liabilities ⓘ	0.28	0.28	0.27	0.26	0.26	0.25	0.25	0.16	0.15	0.03
Fixed Assets
Net Fixed Assets ⓘ +	0.19	0.19	0.18	0.17	0.17	0.16	0.16	0.15	0.15	0
Gross Block	0.40	0.39	0.40	0.40	0.40	0.40	0.39	0.39	0.39	0.01
Accumulated Depreciation	0.21	0.21	0.22	0.23	0.24	0.24	0.24	0.24	0.25	0.01
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	0	0	0	0	0	0	0	0	0	0
Trade Receivables	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0	0	0
Cash Equivalents	0	0	0	0	0	0	0	0	0	0
Others Assets ⓘ	0.06	0.07	0.07	0.07	0.06	0.06	0.06	0	0	0.03
Total Assets ⓘ	0.28	0.28	0.27	0.26	0.26	0.25	0.25	0.16	0.15	0.03

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0.01	0	0	0	-0	0	-2.21	-0.16	-0.06	-0.47
PBT ⓘ	-0.04	-0.05	-0.06	-0.05	-0.06	-0.07	-0.08	-0.17	-0.10	-0.18
Adjustment ⓘ	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.07	0.04	-0.39
Changes in Working Capital ⓘ	0.03	0.04	0.05	0.05	0.05	0.06	-2.13	-0.06	-0	0.09
Tax Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ +	0	0	0	0	0	0	2.21	0.16	0.06	0.59
Capex	0	0	0	0	0	0	0	0	0	0.65
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	2.21	0.16	0.06	-0.06
Cash Flow From Financing Activity ⓘ +	-0.01	0	0	0	0	0	0	0	0	-0.11
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	-0.11
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-0.01	0	0	0	0	0	0	0	0	0
Net Cash Flow ⓘ	-0	0	0	0	-0	0	0	-0	0	-0

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ROCE (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Asset Turnover Ratio	0	0	0	0	0	0	0	0	0	0
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	0	0	0	0	0	0	0	0	0	0
Inventory Days	0	0	0	0	0	0	0	0	0	0
Payable Days	0	0	0	0	0	0	0	0	0	0

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Cresanto Global Ltd FAQs

The current trading price of Cresanto Global on 02-Mar-2026 16:59 is ₹4.43.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Mar-2026 the market cap of Cresanto Global stood at ₹1.89 Cr

The latest P/E ratio of Cresanto Global as of 01-Mar-2026 is 0.00.

The latest P/B ratio of Cresanto Global as of 01-Mar-2026 is -0.68.

The 52-week high of Cresanto Global is ₹4.43 and the 52-week low is ₹3.32.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Cresanto Global is ₹0.05 ( Cr.) .

About Cresanto Global Ltd

Raymed Labs was established in 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities. the company is located at Dehradun Road, Saharanpur, UP. Manufacturing pharmaceutical products, as such, is a specialized job, however, manufacturing of injectables is even more difficult since they are normally given during a life saving situation thus their quality standards are much more stringent. Raymedâ€™s quality quickly won the trusts of doctors and it established itself as one of the leading quality manufacturers of medicines in the area.

Raymed strives on a well organized management team of skilled and highly trained professionals from different streams. This team contains chemists, pharmacists, marketing professionals with in-depth knowledge & requirements for human and animal products.

Products range:

RAMPICILLIN - Ampicillin, a semisynthetic penicillin
RAMPICLOX - Equal quantities of Ampicillin and Cloxacillin
RAMPIMOX - Equal quantities of Amoxycillin and Cloxacillin
RAMYKACIN - Amikacin Sulphate
OXYTETRACYCLINE - The most common Antibiotic in Veterinary Practice
RAMYFENAC-Diclofenac Sodium. It is a potent non steroidal Anti-inflammatory, Analgesic & Antipyretic for human use
RAMAMINE- Chlorpheniramine Maleate. The most potent & effective Anti-histaminic for veterinary use
RAMYDEX-Dexamethasone Sodium Phosphate. Anti-inflammatory, Anti-allergic, Gluco-corticoid adjuvant with Antibiotic therapy
RAMYCIN-Gentamycin Sulphate
RAMYPINE - Atropin Sulphate. The drug has anticholenergic effect in veterinary use.
RAMYCHLOR - Chloramphenicol
REALOPAR - Paracetamol
RAYVIL - Pheniramine Maleate
RAMALGIN-P - Phenylbutazone and Analgin with Lignocaine: A unique combination of highly effective analgesic, antispasmodic, anti-inflammatory & Antipyretic for veterinary use.
RAMYSCAB - Sulphur with Benzyl Benzoate in Lidocaine base: An ideal treatment of Scabies & other dermal problems in animals
RAMYVIT PLEX - Vitamin B1, Vitamin B2, Vitamin B3, Vitamin B12 with Liver Extract: crude injection and ideal treatment of Scabies & other dermal problems in animals

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Cresanto Global Ltd (531207) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Cresanto Global Share Price